维普中文期刊产品整合服务
512篇 您的检索式:作者名="Angiolillo"
    题名 作者 年代 出处 被引量
1Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate显示文摘Laurent Bonello Udaya S. Tantry Rossella Marcucci Ruediger Blindt Dominick J. Angiolillo Richard Becker Deepak L. Bhatt Marco Cattaneo Jean Philippe Collet Thomas Cuisset Christian Gachet Gilles Montalescot Lisa K. Jennings Dean Kereiakes Dirk Sibbing Die 2010Journal of the American College of Cardiology2010,,12:3
2Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease显示文摘Angiolillo DJ Fernandez-Ortiz A Bernardo E 2005Thromb Res2005,116,6:1
3High clopidogrel loading dose during coronary stenting:effects on drug response and interindividual variability显示文摘ANGIOLILLO D J FERNANDEZ-ORTIZ A BERNARDO E 2004Eur Heart J2004,25,21:1
4Interferoninducible protein 10 identified as a mediator of tumor necrosis in vivo 显示文摘Sgadari C Angiolillo AL Cherney BW 1996Proc Natl Acad Sci USA1996,93,13:1
5Platelet function testing and cardiovascular outcomes: steps forward in identifying the best predictive measure显示文摘ANGIOLILLO D J ALFONSO F 2007Thromb Haemost2007,98,4:1
6Randomized Comparison of a High Clopidogrel Maintenance Dose in Patients With Diabetes Mellitus and Coronary Artery Disease Results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) Study显示文摘Angiolillo DJ Shoemaker SB Desai B 2007Circulation2007,115,6:1
7Influence of genetic polymorphisms on the effect of high-and standard-dose clopidogrel after percutaneous coronary intervention: the GIFT (Genotype Information and Functional Testing) study 显示文摘Price MJ Murray SS Angiolillo DJ 2012J Am Coil Cardiol2012,59,22:1
8PlA polymorphism and platelet reactivity following clopidogrel loading dose in patients undergoing coronary stent implantation显示文摘ANGIOLILLO D J FERNANDEZ-ORTIZ A BERNARDO E 2004Blood Coagul Fibrinolysis2004,15,1:1
9Antiplatelet therapy in dlabetes:efficacy and limi- tations of current treatment strategies and future directions显示文摘Angiolillo D J 2009Di- abetes Care2009,32,4:1
10A randomised trial of the pharmacodynamic and pharmacokinetic effects of ticagrelor com- pared with clopidogrel in Hispanic patients with stable coronary artery disease 显示文摘Price M J Clavijo L Angiolillo DJ 2015J Thromb Thrombolysis2015,39,1:1
11Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes显示文摘Robert F. Storey Dominick J. Angiolillo Shankar B. Patil Bhaloo Desai Rosemary Ecob Steen Husted Hakan Emanuelsson Christopher P. Cannon Richard C. Becker Lars Wallentin 2010Journal of the American College of Cardiology2010,,:1
12A phase I clinical, pharmacologic,and biologic study of thrombopoietin and granulocyte colony-stimulating factor in children receiving ifosfamide, carboplatin, and etoposide chemotherapy for recurrent or refractory solid tumors: a Children's Oncology Group experience显示文摘Angiolillo AL Davenport V Bonilla MA 2005Clin Cancer Res2005,11,7:1
13Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy显示文摘Angiolillo DJ Bernardo E Capodanno D 2010J Am Coll Cardiol2010,55,11:1
14Identifying the 'optimal' duration of dual antiplatelet therapy after drug-elu- ting stent revascularization显示文摘Kandzari DE Angiolillo DJ Price MJ 2009JACC Cardiovasc Interv2009,2,12:1
15lnsulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment显示文摘Angiolillo gJ Bernardo E Ramirez C 2006Journal of the American College of Cardiology2006,48,:1
16Impact of Chronic Kidney Disease on Platelet Function Profiles in Diabetes Mellitus Patients With Coronary Artery Disease Taking Dual Antiplatelet Therapy显示文摘Dominick J. Angiolillo Esther Bernardo Davide Capodanno David Vivas Manel Sabaté José Luis Ferreiro Masafumi Ueno Pilar Jimenez-Quevedo Fernando Alfonso Theodore A. Bass Carlos Macaya Antonio Fernandez-Ortiz 2010Journal of the American College of Cardiology2010,,:1
17Variability in responsiveness to oral antiplatelet therapy显示文摘Angiolillo D J 2009Am J Cardiol2009,103,3:1
18Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopi- dogrel treatment显示文摘ANGIOLILLO D J FERNANDEZ-ORTIZ A BRENARDO E 2005Diabetes2005,54,:1
19Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vi-vo显示文摘Angiolillo AL Sgadari C Taub DD 1995J Exp Med1995,182,1:1
20A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy:results of the OPTIMUS-2 study显示文摘Angiolillo DJ Capranzano P Goto S 2008Eur Heart J2008,29,18:1
返回顶部 每页显示:
共26页 首页 上一页 第1页 下一页 末页 /26 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费